Biomet Inc (BMET)
Financials 
Technical Analysis 0
TOP PICK
Has $2 billion in sales. Knee and hip business. Likes this business. Great demographics with an older population. Wonderful cash flow earnings growth. Limited competition so reasonably stable.
Danny TomkaOwned
biotechnologypharmaceutical
TOP PICK
Primary business is the hip/knee replacements. What has generated a product cycle recently is that they can do hips less invasively with only small incisions and knees can be replaced. Stock has been coming off recently. Trades around 19 X earnings. Top line growth is 15% and earnings closer to 20%.
Danny TomkaOwned
biotechnologypharmaceutical
Showing 1 to 8 of 8 entries
- «
- ‹
- 1
- ›
- »
Biomet Inc (BMET) Frequently Asked Questions
What is Biomet Inc stock symbol?
Biomet Inc is a OTC stock, trading under the symbol BMET (previously BMET-Q on Stockchase) on the (). It is usually referred to as or BMET
Is Biomet Inc a buy or a sell?
In the last year, there was no coverage of Biomet Inc published on Stockchase.
Is Biomet Inc a good investment or a top pick?
Biomet Inc was recommended as a Top Pick by David Burrows on 2001-10-16. Read the latest stock experts ratings for Biomet Inc.
Why is Biomet Inc stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
Is Biomet Inc worth watching?
In the last year 0 stock analysts on Stockchase covered Biomet Inc. The stock is worth watching.
